ICU Medical, Inc. Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Million

Consolidate Quarterly Results

Mar'26

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Net Sales

530.37

540.26

537.71

548.70

603.99

628.90

588.39

Other Operating Income

0.00

Total Operating income

530.37

540.26

537.71

548.70

603.99

628.90

588.39

Raw Material Cost

357.28

373.18

335.39

340.41

393.58

404.13

383.44

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

0.00

Power Cost

0.00

Manufacturing Expenses

19.75

24.84

25.14

26.38

29.02

31.23

34.31

Selling and Distribution Expenses

121.14

122.18

152.77

159.39

157.23

158.85

162.71

Other Expenses

0.15

-0.38

-0.39

-0.45

-0.57

-0.89

-1.33

Total Expenditure (Excl Depreciation)

499.70

516.45

509.41

521.67

574.10

585.34

567.17

Operating Profit (PBDIT) excl Other Income

30.7

23.799999999999997

28.3

29.900000000000002

43.6

21.200000000000003

Other Income

1.90

5.57

7.47

49.24

4.92

4.25

8.04

Operating Profit (PBDIT)

82.60

83.73

86.57

125.94

84.25

100.80

84.94

Interest

19.75

24.84

25.14

26.38

29.02

31.23

34.31

Exceptional Items

-16.80

-20.45

-13.14

-16.22

-16.70

-8.36

-12.88

Gross Profit (PBDT)

173.10

167.08

202.32

208.29

210.41

224.76

204.96

Depreciation

50.03

54.34

50.80

49.66

49.45

52.99

55.67

Profit Before Tax

-3.98

-15.90

-2.51

33.68

-10.91

8.22

-17.93

Tax

-34.71

-2.65

-0.66

1.18

4.57

32.05

15.05

Provisions and contingencies

0.00

Profit After Tax

30.13

-15.73

-3.40

35.34

-15.48

-23.83

-32.98

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

30.13

-15.73

-3.40

35.34

-15.48

-23.83

-32.98

Share in Profit of Associates

0.00

Minority Interest

0.00

Other related items

0.00

Consolidated Net Profit

30.13

-15.73

-3.40

35.34

-15.48

-23.83

-32.98

Equity Capital

0.00

Face Value

0.1

Reserves

2,111.93

2,123.82

2,127.25

2,115.78

1,987.69

1,965.23

2,048.59

Earnings per share (EPS)

1.2

-0.64

-0.14

1.43

-0.63

-0.97

-1.35

Diluted Earnings per share

1.2

-0.64

-0.14

1.43

-0.63

-0.97

-1.35

Operating Profit Margin (Excl OI)

5.78%

4.41%

5.26%

4.93%

4.95%

6.93%

3.61%

Gross Profit Margin

8.68%

7.11%

8.98%

15.19%

6.38%

9.73%

6.42%

PAT Margin

5.68%

-2.91%

-0.63%

6.44%

-2.56%

-3.79%

-5.61%

Public Share Holdings (%)

0.0%

Pledged Promotor Holding (%)

0.0%

Quarterly Analysis Highlights - QoQ

Net Sales

QoQ Growth in quarter ended Mar 2026 is -1.83% vs 0.48% in Dec 2025

Consolidate Net Profit

QoQ Growth in quarter ended Mar 2026 is 291.72% vs -361.76% in Dec 2025

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2026 is 3.20% vs -1.14% in Dec 2025

Interest

QoQ Growth in quarter ended Mar 2026 is -20.16% vs -1.20% in Dec 2025

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

Compare Quarterly Results Of ICU Medical, Inc. With

Select Peers

Figures in Million

Consolidate Quarterly Results

Change(USD)

Change(%)

Net Sales

530.37

116.19

414.18

356.47%

Other Operating Income

0.00

Total Operating income

530.37

116.19

414.18

356.47%

Raw Material Cost

357.28

28.76

328.52

1,142.28%

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

0.00

Power Cost

0.00

Manufacturing Expenses

19.75

0.00

19.75

Selling and Distribution Expenses

121.14

76.73

44.41

57.88%

Other Expenses

0.15

1.35

-1.20

-88.89%

Total Expenditure (Excl Depreciation)

499.70

118.99

380.71

319.95%

Operating Profit (PBDIT) excl Other Income

30.68

-2.79

33.47

1,199.64%

Other Income

1.90

4.71

-2.81

-59.66%

Operating Profit (PBDIT)

82.60

5.63

76.97

1,367.14%

Interest

19.75

0.00

19.75

Exceptional Items

-16.80

-3.47

-13.33

-384.15%

Gross Profit (PBDT)

173.10

87.43

85.67

97.99%

Depreciation

50.03

3.71

46.32

1,248.52%

Profit Before Tax

-3.98

-1.56

-2.42

-155.13%

Tax

-34.71

-1.53

-33.18

-2,168.63%

Provisions and contingencies

0.00

Profit After Tax

30.13

-0.02

30.15

150,750.00%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

30.13

-0.02

30.15

150,750.00%

Share in Profit of Associates

0.00

Minority Interest

0.00

Other related items

0.00

Consolidated Net Profit

30.13

-0.02

30.15

150,750.00%

Equity Capital

0.00

Face Value

0.10

0.00

Reserves

2,111.93

664.49

1,447.44

217.83%

Earnings per share (EPS)

1.20

-0.00

1.20

Diluted Earnings per share

1.20

-0.00

1.20

Operating Profit Margin (Excl OI)

5.78%

-2.40%

0.00

8.18%

Gross Profit Margin

8.68%

1.86%

0.00

6.82%

PAT Margin

5.68%

-0.02%

0.00

5.70%

Public Share Holdings (%)

0.00

0.00%

Pledged Promotor Holding (%)

0.00

0.00%

Quarterly - Net Sales

Net Sales 53.04 Million

in Mar 2026

Figures in Million

QoQ Growth in quarter ended Mar 2026 is -1.83% vs 0.48% in Dec 2025

YoY Growth in quarter ended Mar 2026 is -12.19% vs 6.71% in Mar 2025

Quarterly - Consolidate Net Profit

Consolidate Net Profit 3.01 Million

in Mar 2026

Figures in Million

QoQ Growth in quarter ended Mar 2026 is 291.72% vs -361.76% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 294.19% vs 60.76% in Mar 2025

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 8.07 Million

in Mar 2026

Figures in Million

QoQ Growth in quarter ended Mar 2026 is 3.20% vs -1.14% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 1.77% vs 33.73% in Mar 2025

Quarterly - Interest

Interest 1.98 Million

in Mar 2026

Figures in Million

QoQ Growth in quarter ended Mar 2026 is -20.16% vs -1.20% in Dec 2025

YoY Growth in quarter ended Mar 2026 is -31.72% vs -15.70% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 5.78%

in Mar 2026

Figures in %

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025